Share

March 16, 2021



We are doing this review following concerns that "about adverse cases after vaccination with AstraZeneca against Covid-19, EMA director Emer Cooke said at a press conference." Our priority is to ensure safety of the vaccine, "he added. 



The press conference is being held, for" an update on the ongoing investigation into AstraZeneca's vaccine and thromboembolic events. "



It is expected to last until 3pm and is organized by the European Commission.